← SynDRA
SUPLATAST
SynDRA canonical compound SYN0022805 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Mechanism of action | histamine release inhibitor | immunoglobulin inhibitor |
|---|
| Indication | Kimura's disease |
|---|
| Disease area | rheumatology |
|---|
Mechanisms of action (all sources)
- histamine release inhibitor
- immunoglobulin inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ADORA1
- ADORA2A
- HTR1A
- HTR2A
- HTR2B
- HTR2C
- HTR3A
- KCNH2
- MAOA
- MC3R
- MLNR
- NR1I2
- NR3C1
- OPRD1
- OPRM1
- PDE3A
- PDE4D
- PGR
- PPARG
- PTGS2
- SLC29A1
- SLC6A2
- SLC6A3
- HRH3
- HRH1
- HDAC6
- CCKAR
- ADORA3
- ADRA1A
- ADRA2A
- ADRA2B
- ADRA2C
- ADRB1
- ADRB2
- AGTR1
- AVPR1A
- CHRM1
- GHSR
- CHRM2
- CHRM3
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Anti-Allergic Agents
- Histamine Agents
- Histamine Antagonists
- Neurotransmitter Agents
Cross-references
Synonyms
- suplatast tosylate
- suplatast tosilate
- Suplatast cation
- Suplatast ion
- UNII-4T0HO29O56
- 4T0HO29O56
- NCGC00181000-01
- SCHEMBL1009112
- CHEBI:32172
- NCGC00181000-03
- NCGC00181000-09
- AB01566844_01
- BRD-A98427211-075-02-0
- BRD-A98427211-075-03-8
- BRD-A98427211-075-04-6
- BRD-A98427211-075-05-3
- CAS-94055-76-2
- NCGC00181000-02
- SY103643
- UNII-C9J89787U1
- C77240
- SUPLATAST TOSILATE [MART.]
- IPD-1151T
- SUPLATAST TOSILATE [JAN]
- Tosilate de suplatast [INN-French]
- YM-672
- Tosilate de suplatast
- CCRIS 6596
- Tosilato de suplatast [INN-Spanish]
- Suplatast Tosilate
- スプラタストトシル酸塩
- Suplatasttosilate
- HMS5080F15
- SUPLATAST TOSILATE [WHO-DD]
- Tox21_112652_1
- NS00121209
- SW219352-1
Look up SUPLATAST in the interactive SynDRA portal →